Notes from underground: Are cognitive-enhancing drugs respecting their promises?

Frontiers in Psychology

Volumn , Issue SEP, 2010, Pages

  Larøi, Frank ^a,b   Raballo, Andrea ^c,d  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Intercommunale de Soins Specialises de Liege Mental Health Sector   (Belgium)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d PATHOLOGY UNIT   (Italy)

Author keywords

Antipsychotics; Cognition; Neuroleptics; Neuropsychology; Schizophrenia

Indexed keywords

EID: 84866753242     PISSN: None     EISSN: 16641078     Source Type: Journal    
DOI: 10.3389/fpsyg.2010.00158     Document Type: Article

References (30)

1. Couture, S. M., Penn, D. L., and Roberts, D. L. (2006). The functional significance of social cognition in schizophrenia: a review. Schizophr. Bull. 32(Suppl. 1), 44-63.
2. Davidson, M., Galderisi, S., Weiser, M., Werbeloff, N., Fleischhacker, W. W., Keefe, R. S., Boter, H., Keet, I. P., Prelipceanu, D., Rybakowski, J. K., Libiger, J., Hummer, M., Dollfus, S., López-Ibor, J. J., Hranov, L. G., Gaebel, W., Peuskens, J., Lindefors, N., Riecher-Rössler, A., and Kahn, R. S. (2009). Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am. J. Psychiatry 166, 675-682.
3. Fagerlund, B., Søholm, B., Fink-Jensen, A., Lublin, H., and Glenthøj, B. Y. (2007). Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study. Clin. Neuropharmacol. 30, 3-12.
4. Freudenreich, O., Henderson, D. C., Macklin, E. A., Evins, A. E., Fan, X., Cather, C., Walsh, J. P., and Goff, D. C. (2009). Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial. J. Clin. Psychiatry 70, 1674-1680.
5. Freudenreich, O., Herz, L., Deckersbach, T., Evins, A. E., Henderson, D. C., Cather, C., and Goff, D. C. (2005). Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology 181, 358-363.
6. Friedman, J. I., Adler, D. N., Howanitz, E., Harvey, P. D., Brenner, G., Temporini, H., White, L., Parrella, M., and Davis, K. L. (2002). A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biol. Psychiatry 51, 349-357.
7. Green, M. F. (2007). Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions. Am. J. Psychiatry 164, 992-994.
8. Green, M. F., and Nuechterlein, K. H. (2004). The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr. Res. 72, 1-3.
9. Harvey, P. D. (2009). Pharmacological cognitive enhancement in schizophrenia. Neuropsychol. Rev. 19, 324-335.
10. Heinrichs, R. W. (2005). The primacy of cognition in schizophrenia. Am. Psychol. 60, 229-242.
11. Heinrichs, R. W. (2007). Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch. Gen. Psychiatry 64, 631-632.
12. Keefe, R. S. E., Bilder, R. M., Davis, S. M., Harvey, P. D., Palmer, B. W., Gold, J. M., Meltzer, H. Y., Green, M. F., Capuano, G., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Davis, C. E., Hsiao, J. K., and Lieberman, J. A. (2007). Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch. Gen. Psychiatry 64, 633-647.
13. Keefe, R. S. E., Malhotra, A. K., Meltzer, H. Y., Kane, J. M., Buchanan, R. W., Murthy, A., Sovel, M., Li, C., and Goldman, R. (2008). Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology 33, 1217-1228.
14. Krabbendam, L., and Aleman, A. (2003). Cognitive rehabilitation in schizophrenia: a quantitative analysis of controlled studies. Psychopharmacology 169, 376-382.
15. Kraus, M. S., and Keefe, R. S. E. (2007). Cognition as an outcome measure in schizophrenia. Br. J. Psychiatry 191, 46-51.
16. Kurtz, M. M., Moberg, P. J., Gur, R. C., and Gur, R. E. (2001). Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis. Neuropsychol. Rev. 11, 197-210.
17. Larøi, F., and Van der Linden, M. (2007). Revalidation cognitive et schizophrénie: pour une approche individualisée et centrée sur les activités de la vie quotidienne. Lett. Psychiatre 3, 50-53.
18. Levaux, M.-N., Vezzaro, J., Larøi, F., Van der Linden, M., Offerlin-Meyer, I., and Danion, J.-M. (2009). Cognitive remediation of the updating sub-component of working memory in schizophrenia: a single-case study. Neuropsychol. Rehabil. 19, 244-273.
19. Marder, S. R., and Fenton, W. (2004). Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr. Res. 72, 5-9.
20. McGurk, S. R., Twamley, E. W., Sitzer, D. I., McHugo, G. J., and Mueser, K. T. (2007). A meta-analysis of cognitive remediation in schizophrenia. Am. J. Psychiatry 164, 1791-1802.
21. Medalia, A., and Choi, J. (2009). Cognitive remediation in schizophrenia. Neuropsychol. Rev. 19, 353-364.
22. Mishara, A. L., and Goldberg, T. E. (2004). A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol. Psychiatry 55, 1013-1022.
23. Moritz, S., and Woodward, T. S. (2007). Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention. Curr. Opin. Psychiatry 20, 619-625.
24. Palmer, B. W., Dawes, S. E., and Heaton, R. K. (2009). What do we know about neuropsychological aspects of schizophrenia? Neuropsychol. Rev. 19, 365-384.
25. Penn, D. L., Sanna, L. J., and Roberts, D. L. (2008). Social cognition in schizophrenia: an overview. Schizophr. Bull. 34, 408-411.
26. Pilling, S., Bebbington, P., Kuipers, E., Garety, P., Geddes, J., Martindale, B., Orbach, G., and Morgan, C. (2002). Psychological treatments in schizophrenia: II. Meta-analyses of randomized controlled trials of social skills training and cognitive remediation. Psychol. Med. 32, 783-791.
27. Suslow, T., Schonauer, K., and Arolt, V. (2001). Attention training in the cognitive rehabilitation of schizophrenic patients: a review of efficacy studies. Acta Psychiatr. Scand. 103, 15-23.
28. Tugal, Ö., Yazici, K. M., Yagcioglu, E. A., and Gögüs, A. (2004). A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia. Int. J. Neuropsychopharmacol. 7, 117-123.
29. Twamley, E. W., Jeste, D. V., and Bellack, A. S. (2003). A review of cognitive training in schizophrenia. Schizophr. Bull. 29, 359-382.
30. Wexler, B. E., and Bell, M. D. (2005). Cognitive remediation and vocational rehabilitation for schizophrenia. Schizophr. Bull. 31, 931-941.